Skip to main content
Log in

Risperidone-Induced Galactorrhea Associated with a Prolactin Elevation

Annals of Clinical Psychiatry

Abstract

We report on the occurrence of galactorrhea associated with a prolactin elevation within weeks of treatment with risperidone. One of our patients was switched to a typical antipsychotic, with an improvement in the galactorrhea. The other patient was continued on risperidone due to a robust response, while her galactorrhea was partially treated with bromocriptine. The mechanism of prolactin elevation with risperidone is unclear. These cases suggest the need for further studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Marder SR, Meibach RC: Risperidone in the treatment of Schizophrenia. Am J Psychiatry 1994; 151:825–835

    Google Scholar 

  2. Gupta S, Black DW, Smith DA: Risperidone: Review of its pharmacology, and therapeutic use in schizophrenia. Ann Clin Psychiatry 1994; 6:173–180

    Google Scholar 

  3. Bersani G, Grisfini A, Marini S, Pasini A, Valducci M, Ciani M: Neuroleptic-induced extrapyramidal side effects: Clinical perspectives with ritanserin (R 55 667), a new selective 5-HT2 receptor blocking agent. Curr Ther Res 1986; 40:492–499

    Google Scholar 

  4. Casey DE: What makes a neuroleptic atypical? In: Meltzer HY, ed. Novel Antipsychotic Drugs. New York, Raven Press; 1992:241–251

    Google Scholar 

  5. Kerwin RW: The new atypical antipsychotics: A lack of extrapyramidal side-effects and new routes in schizophrenia research. Br J Psychiatry 1994; 164:141–148

    Google Scholar 

  6. Casey DE: Clozapine: Neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacology 1989; 99:S47-S53

    Google Scholar 

  7. Meltzer HY, Goode DJ, Schyve PM, Young M, Fang VS: Effect of clozapine on human serum prolactin levels. Am J Psychiatry 1979; 136:1550–1555

    Google Scholar 

  8. Schotte A, Janssen PFM, Gommeren, Luyten WHML, Gompel PV, Lesage AS, Loore KD, Leysen JE: Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding. Psychopharmacology 1996; 124:57–73

    Google Scholar 

  9. Dickinson RA, Dalby JT, Williams R, Edwards AL: Risperidone-induced prolactin elevations in premenopausal women with schizophrenia. Am J Psychiatry 1995; 157:1102–1103

    Google Scholar 

  10. Hardan A, Johnson K, Johnson C, Hrecznyj B: Case Study: Risperidone treatment of children and adolescents with developmental disorders. J Am Acad Child Adolesc Psychiatry 1996; 35:1551–1556

    Google Scholar 

  11. Frantz AG, Kleinberg DL, Noel GL: Studies on prolactin in man. Rec Prog Horm Res 1972; 28:527–598

    Google Scholar 

  12. Adams JB: Human breast cancer: Concerned role of diet, prolactin and adrenal C19–5-steroids. Int J Cancer 1992; 50:854–858

    Google Scholar 

  13. Gold EB, Bush T, Chee E: Risk factors for secondary amenorrhea and galactorrhea. Int J Fertil Menopausal Stud 1994; 39(3):177–184

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Popli, A., Gupta, S. & Rangwani, S.R. Risperidone-Induced Galactorrhea Associated with a Prolactin Elevation. Ann Clin Psychiatry 10, 31–33 (1998). https://doi.org/10.1023/A:1026150629199

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026150629199

Navigation